Skip to main content
ConductScienceScienceDex

Gray, Joe W.

From the FY2019 NIH awards this investigator leads as contact PI. The department is the award's.

FY2019 NIH rank #5,318
Unclaimed recordClaim profile
  • Rising Star
  • Sustained Excellence
  • Program Leader
  • Long-Funded

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2001 through FY2019Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2019

Linked Award Amount
$1.4M
Full award amounts, FY2019
Award Records
3
Records listing this PI
Award-Linked Rank
#5,318
By linked amount among FY2019 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Gray, Joe W.. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2019 award records by amount

NIH award records listing Gray, Joe W. as a PI. Multi-PI records show the full award amount for context.

  • 5U01CA195469-05U01Contact PI
    Intratumor heterogeneity underlying treatment resistance in HER2+ breast tumors
    Dana-Farber Cancer Institute
    $645.6K
    award amount
  • 6R44CA217534-04R44Contact PI
    Nanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer
    Pdx Pharmaceuticals, Inc.
    $513.4K
    award amount
  • 5R44CA217534-03R44Contact PI
    Nanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer
    Pdx Pharmaceuticals, Inc.
    $233.9K
    award amount

Award organizations

Organizations that administered FY2019 awards listing Gray, Joe W. as a PI.

Pdx Pharmaceuticals, Inc.
OR
$747.2K
2 grants
Dana-Farber Cancer Institute
MA
$645.6K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2001
    First NIH Award
    Pdx Pharmaceuticals, Inc.
  2. 2001
    $500K Cumulative Funding
  3. 2001
    $1M Cumulative Funding
  4. 2001
    $2M Cumulative Funding
  5. 2001
    Entered Top 50% Nationally
    Ranked #423
  6. 2001
    Entered Top 25% Nationally
    Ranked #423
  7. 2001
    Entered Top 10% Nationally
    Ranked #423
  8. 2001
    Entered Top 5% Nationally
    Ranked #423
  9. 2002
    Multi-Institutional Research
    Awards at 2 institutions
  10. 2003
    $5M Cumulative Funding
  11. 2004
    $10M Cumulative Funding
  12. 2015
    Program/Center Grant Leader

Explore further

Find collaborators for Gray, Joe W.

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →